LGND - Ligand Pharmaceuticals Incorporated (LGND) CEO John Higgins on Q3 2019 Results - Earnings Call Transcript
Ligand Pharmaceuticals Incorporated (LGND)
Q3 2019 Earnings Conference Call
November 5, 2019 04:30 PM ET
Company Participants
Patrick O’Brien - SVP of Investor Relations
John Higgins - CEO
Matt Foehr - COO
Matt Korenberg - CFO
Conference Call Participants
Lucas Baranowski - Craig-Hallum
Emanuela Branchetti - H.C. Wainwright
Scott Henry - Roth Capital Partners
Peter Lukas - CJS Securities
Presentation
Operator
Hello, and welcome to this webcast, Ligand Pharmaceuticals' Third Quarter 2019 Earnings Call. My name is Lira and I will be your event specialist today. Please note that all lines have been placed on